National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 526572

Case Details

VAERS ID: 526572 (history)  
Form: Version 1.0  
Age: 16.0  
Gender: Female  
Location: Michigan  
   Days after vaccination:11
Submitted: 2014-03-25
   Days after onset:927
Entered: 2014-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Coeliac disease, Fatigue, Gait disturbance, Immunoglobulin therapy, Muscular weakness, Myalgia, Myasthenia gravis
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Eosinophilic pneumonia (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1403USA010855

Write-up: This spontaneous report as received from a physician refers to a 16 year old female patient. On 30-AUG-2011 the patient was vaccinated with GARDASIL, 0.5 ml, intramuscular. The dose number, the lot number and expiration date of the vaccine, the route of administration and anatomical location of the vaccination were not reported. On 10-SEP-2011, reported as 11 days after the date of vaccination the patient experienced celiac disease (disability, medically significant upon internal review), tripping down the stairs because her legs were so weak (disability), muscle pain (disability), extreme fatigue (disability), myasthenia gravis (disability, medically significant upon internal review) and being so weak that she had issue lifting her arms (disability). Disability was reported as serious criterion, the event(s) to which this referred however were not specified. Treatment for the myasthenia gravis included MESTINON, IVIG and Prednisone. The outcome of celiac disease, tripping down the stairs, muscle pain, extreme fatigue and myasthenia gravis was reported as not recovered/not resolved. The physician reported that all adverse effects were progressing. No causality statement was reported for any of the events in relation to GARDASIL. Additional information has been requested.

New Search

Link To This Search Result:

Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166